 |
10 Diseases |  |
0 Trials |
|
0 Trials |  |
56 News |  |
| «12 |
- ||||| apararenone (MT-3995) / Mitsubishi Tanabe
New P2 trial: A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR (clinicaltrials.gov) - Dec 25, 2012
P2, N=90, Recruiting, Sponsor: Mitsubishi Tanabe Pharma Corporation
- ||||| apararenone (MT-3995) / Mitsubishi Tanabe
New P2 trial: A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria (clinicaltrials.gov) - Dec 25, 2012
P2, N=90, Recruiting, Sponsor: Mitsubishi Tanabe Pharma Corporation